Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas
This review summarizes the classification of tumors of the adrenal medulla and extra-
adrenal paraganglia as outlined in the 5th series of the WHO Classification of Endocrine and …
adrenal paraganglia as outlined in the 5th series of the WHO Classification of Endocrine and …
Update from the 5th edition of the world health organization classification of head and neck tumors: overview of the 2022 WHO classification of head and neck …
O Mete, BM Wenig - Head and neck pathology, 2022 - Springer
This review article provides a brief overview of the new WHO classification by adopting a
question–answer model to highlight the spectrum of head and neck neuroendocrine …
question–answer model to highlight the spectrum of head and neck neuroendocrine …
Current management of pheochromocytoma/paraganglioma: a guide for the practicing clinician in the era of precision medicine
S Nölting, M Ullrich, J Pietzsch, CG Ziegler… - Cancers, 2019 - mdpi.com
Pheochromocytomas and paragangliomas (PCC/PGLs) are rare, mostly catecholamine-
producing neuroendocrine tumors of the adrenal gland (PCCs) or the extra-adrenal …
producing neuroendocrine tumors of the adrenal gland (PCCs) or the extra-adrenal …
The North American Neuroendocrine Tumor Society consensus guidelines for surveillance and management of metastatic and/or unresectable pheochromocytoma …
L Fishbein, J Del Rivero, T Else, JR Howe, SL Asa… - Pancreas, 2021 - journals.lww.com
This manuscript is the result of the North American Neuroendocrine Tumor Society
consensus conference on the medical management and surveillance of metastatic and …
consensus conference on the medical management and surveillance of metastatic and …
The diagnosis and clinical significance of paragangliomas in unusual locations
Paragangliomas are neuroendocrine neoplasms, derived from paraganglia of the
sympathetic and parasympathetic nervous systems. They are most commonly identified in …
sympathetic and parasympathetic nervous systems. They are most commonly identified in …
A clinicopathologic and molecular analysis of fumarate hydratase-deficient renal cell carcinoma in 32 patients
HD Lau, E Chan, AC Fan, CA Kunder… - The American journal …, 2020 - journals.lww.com
Fumarate hydratase-deficient renal cell carcinoma (FH-deficient RCC) is a rare and recently
described entity associated with hereditary leiomyomatosis and RCC syndrome. FH …
described entity associated with hereditary leiomyomatosis and RCC syndrome. FH …
Challenges in paragangliomas and pheochromocytomas: from histology to molecular immunohistochemistry
CC Juhlin - Endocrine pathology, 2021 - Springer
Abdominal paragangliomas and pheochromocytomas (PPGLs) are rare neuroendocrine
tumors of the infradiaphragmatic paraganglia and adrenal medulla, respectively. Although …
tumors of the infradiaphragmatic paraganglia and adrenal medulla, respectively. Although …
[HTML][HTML] Pheochromocytoma/paraganglioma: recent updates in genetics, biochemistry, immunohistochemistry, metabolomics, imaging and therapeutic options
K Antonio, MMN Valdez, L Mercado-Asis, D Taïeb… - Gland …, 2020 - ncbi.nlm.nih.gov
Pheochromocytomas and paragangliomas (PPGLs), rare chromaffin/neural crest cell tumors,
are commonly benign in their clinical presentation. However, there are a number of cases …
are commonly benign in their clinical presentation. However, there are a number of cases …
COPPS, a composite score integrating pathological features, PS100 and SDHB losses, predicts the risk of metastasis and progression-free survival in …
C Pierre, M Agopiantz, L Brunaud, SF Battaglia-Hsu… - Virchows Archiv, 2019 - Springer
Current histoprognostic parameters and prognostic scores used in paragangliomas and
pheochromocytomas do not adequately predict the risk of metastastic progression and …
pheochromocytomas do not adequately predict the risk of metastastic progression and …
Hereditary leiomyomatosis and renal cell carcinoma syndrome (HLRCC): a contemporary review and practical discussion of the differential diagnosis for HLRCC …
SL Skala, SM Dhanasekaran… - Archives of pathology & …, 2018 - meridian.allenpress.com
Context.—Hereditary leiomyomatosis and renal cell carcinoma syndrome (HLRCC) is an
uncommon disorder with germline-inactivating mutations in the fumarate hydratase (FH) …
uncommon disorder with germline-inactivating mutations in the fumarate hydratase (FH) …